Thromboembolism

·MeSH: Venous Thromboembolism

7 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Approved(1)

Drug	Company
bevyxxa	PORTOLA PHARMACEUTICALS INC (PTLA)

Phase 3(3)

Drug	Company
abelacimab	Dianthus Therapeutics, Inc. /DE/ (DNTH)
acetylsalicylic acid	REGENERON PHARMACEUTICALS, INC. (REGN)
dalteparin	Dianthus Therapeutics, Inc. /DE/ (DNTH)

Phase 2(2)

Drug	Company
regn7508	REGENERON PHARMACEUTICALS, INC. (REGN)
regn9933	REGENERON PHARMACEUTICALS, INC. (REGN)

Phase 2/Phase 3(1)

Drug	Company
tecarfarin	Cadrenal Therapeutics, Inc. (CVKD)

BioSniper tracks 7 drugs in development for Thromboembolism across 4 companies.

There are 1 clinical trial targeting Thromboembolism tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.